These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11867194)

  • 1. A long-awaited small animal model for hepatitis C.
    Guha C; Chowdhury JR
    J Hepatol; 2002 Mar; 36(3):447-9. PubMed ID: 11867194
    [No Abstract]   [Full Text] [Related]  

  • 2. A mouse model for hepatitis C virus infection?
    Fausto N
    Nat Med; 2001 Aug; 7(8):890-1. PubMed ID: 11479615
    [No Abstract]   [Full Text] [Related]  

  • 3. Infection by proxy: the role of chimeric mice in HBV and HCV research.
    Perkins JD
    Liver Transpl; 2006 Feb; 12(2):323. PubMed ID: 16568562
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal model for study of human hepatitis viruses.
    Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
    J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
    Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New animal models of hepatitis B and C.
    Feitelson MA; Larkin JD
    ILAR J; 2001; 42(2):127-38. PubMed ID: 11406715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice.
    Meuleman P; Vanlandschoot P; Leroux-Roels G
    Biochem Biophys Res Commun; 2003 Aug; 308(2):375-8. PubMed ID: 12901879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
    Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
    J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus viremia in SCID-->BNX mouse chimera.
    Galun E; Burakova T; Ketzinel M; Lubin I; Shezen E; Kahana Y; Eid A; Ilan Y; Rivkind A; Pizov G
    J Infect Dis; 1995 Jul; 172(1):25-30. PubMed ID: 7797923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
    Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
    Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host and viral determinants for engraftment of virus permissive human hepatocytes into chimeric immunodeficient mice.
    Robinet E; Baumert TF
    J Hepatol; 2010 Sep; 53(3):421-3. PubMed ID: 20561706
    [No Abstract]   [Full Text] [Related]  

  • 12. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of humanized mice for the study of hepatitis C virus infection.
    Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
    Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethality in mice infected with recombinant vaccinia virus expressing hepatitis C virus core protein.
    Zhang H
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):374-82. PubMed ID: 14599943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
    Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
    Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new hypothesis of pathogenetic mechanism of viral hepatitis B and C.
    Liu DX
    Med Hypotheses; 2001 Mar; 56(3):405-8. PubMed ID: 11359371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model.
    Soguero C; Joo M; Chianese-Bullock KA; Nguyen DT; Tung K; Hahn YS
    J Virol; 2002 Sep; 76(18):9345-54. PubMed ID: 12186917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A murine model for an ignored chronic infection: hepatitis E !].
    Gilgenkrantz H; Gouttenoire J; Mallet V
    Med Sci (Paris); 2016 Oct; 32(10):812-814. PubMed ID: 27758738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basically, is there a possibility for therapy with ovulation inhibitors in hepatitis C with virus persistence and in the acute stage?].
    Gerken G
    Internist (Berl); 1995 Apr; 36(4):410-1. PubMed ID: 7775094
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.